Pictorial Warning Labels and Memory for Relative and Absolute Cigarette Health-risk Information Over Time in Teens
NCT ID: NCT03500965
Last Updated: 2018-04-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
422 participants
INTERVENTIONAL
2016-05-25
2018-01-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pictorial Warning Labels & Memory for Relative & Absolute Cigarette Health-risk Information Over Time in Adult Smokers
NCT03499340
Pictorial Warning Labels and Memory for Cigarette Health-risk Information Over Time
NCT03375840
Pictorial Warning Labels, Numeracy, and Memory for Numeric Cigarette Health-risk Information Over Time
NCT03501472
FDA Cigarette Warning Labels: Eye Tracking Study
NCT04936724
Effects of Implicit Messaging by Cigarette Pack Color on Smoking Behaviors
NCT02301351
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Text-only PWL, absol risk
Exposure to FDA-mandated warning labels, without a graphic image, accompanied by risk information about smoker's risk of a smoking-related disease
text-only PWL
control condition (no image)
absolute risk
Percentage risk information for smoking-related diseases for smokers
text-only PWL, relative risk
Exposure to FDA-mandated warning labels, without a graphic image, accompanied by risk information about smoker's risk and non-smoker's risk of a smoking-related disease
text-only PWL
control condition (no image)
relative risk
Percentage risk information for smoking-related diseases for smokers and non-smokers
graphic PWL, absol risk
Exposure to FDA-mandated warning labels, paired with a graphic image, accompanied by risk information about smoker's risk of a smoking-related disease
graphic PWL
pictorial warning
absolute risk
Percentage risk information for smoking-related diseases for smokers
graphic PWL, relative risk
Exposure to FDA-mandated warning labels, paired with a graphic image, accompanied by risk information about smoker's risk and non-smoker's risk of a smoking-related disease
graphic PWL
pictorial warning
relative risk
Percentage risk information for smoking-related diseases for smokers and non-smokers
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
text-only PWL
control condition (no image)
graphic PWL
pictorial warning
absolute risk
Percentage risk information for smoking-related diseases for smokers
relative risk
Percentage risk information for smoking-related diseases for smokers and non-smokers
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* report vulnerability to smoking (i.e., report that they might smoke in the next year or would try a cigarette if a friend offered one)
* parents give permission to participate
Exclusion Criteria
* parents do not provide permission to participate
14 Years
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Pennsylvania
OTHER
Ohio State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ellen Peters
Professor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P50CA180908A2a-T
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.